Literature DB >> 8799185

Agonist-selective endocytosis of mu opioid receptor by neurons in vivo.

C Sternini1, M Spann, B Anton, D E Keith, N W Bunnett, M von Zastrow, C Evans, N C Brecha.   

Abstract

Opiate alkaloids are potent analgesics that exert multiple pharmacological effects in the nervous system by activating G protein-coupled receptors. Receptor internalization upon stimulation may be important for desensitization and resensitization, which affect cellular responsiveness to ligands. Here, we investigated the agonist-induced internalization of the mu opioid receptor (MOR) in vivo by using the guinea pig ileum as a model system and immunohistochemistry with an affinity-purified antibody to the C terminus of rat MOR. Antibody specificity was confirmed by the positive staining of human embryonic kidney 293 cells transfected with epitope-tagged MOR cDNA, by the lack of staining of cells transfected with the delta or kappa receptor cDNA, and by the abolition of staining when the MOR antibody was preadsorbed with the MOR peptide fragment. Abundant MOR immunoreactivity (MOR-IR) was localized to the cell body, dendrites, and axonal processes of myenteric neurons. Immunostaining was primarily confined to the plasma membrane of cell bodies and processes. Within 15 min of an intraperitoneal injection of the opiate agonist etorphine, intense MOR-IR was present in vesicle-like structures, which were identified as endosomes by confocal microscopy. At 30 min, MOR-IR was throughout the cytoplasm and in perinuclear vesicles. MOR-IR was still internalized at 120 min. Agonist-induced endocytosis was completely inhibited by the opiate antagonist naloxone. Interestingly, morphine, a high-affinity MOR agonist, did not cause detectable internalization, but it partially inhibited the etorphine-induced MOR endocytosis. These results demonstrate the occurrence of agonist-selective MOR endocytosis in neurons naturally expressing this receptor in vivo and suggest the existence of different mechanisms regulating cellular responsiveness to ligands.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8799185      PMCID: PMC38626          DOI: 10.1073/pnas.93.17.9241

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Ligand-regulated internalization and recycling of human beta 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors.

Authors:  M von Zastrow; B K Kobilka
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

Review 2.  Opioid receptors and their pharmacological profiles.

Authors:  R A Lutz; H P Pfister
Journal:  J Recept Res       Date:  1992

Review 3.  Endogenous opiates: 1987.

Authors:  G A Olson; R D Olson; A J Kastin
Journal:  Peptides       Date:  1989 Jan-Feb       Impact factor: 3.750

Review 4.  Opioid receptors and endogenous opioid peptides.

Authors:  E J Simon
Journal:  Med Res Rev       Date:  1991-07       Impact factor: 12.944

5.  Calcitonin gene-related peptide-containing neurons supplying the rat digestive system: differential distribution and expression pattern.

Authors:  C Sternini; K Anderson
Journal:  Somatosens Mot Res       Date:  1992       Impact factor: 1.111

Review 6.  Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion.

Authors:  W Kromer
Journal:  Pharmacol Rev       Date:  1988-06       Impact factor: 25.468

Review 7.  Structural and chemical organization of the myenteric plexus.

Authors:  C Sternini
Journal:  Annu Rev Physiol       Date:  1988       Impact factor: 19.318

8.  Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization.

Authors:  S S Yu; R J Lefkowitz; W P Hausdorff
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

9.  Distribution and projections of nerves with enkephalin-like immunoreactivity in the guinea-pig small intestine.

Authors:  J B Furness; M Costa; R J Miller
Journal:  Neuroscience       Date:  1983-04       Impact factor: 3.590

Review 10.  Neurobiology of opiate abuse.

Authors:  G Di Chiara; R A North
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

View more
  98 in total

1.  Regulation of the subcellular distribution of m4 muscarinic acetylcholine receptors in striatal neurons in vivo by the cholinergic environment: evidence for regulation of cell surface receptors by endogenous and exogenous stimulation.

Authors:  V Bernard; A I Levey; B Bloch
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  Recycling and resensitization of delta opioid receptors.

Authors:  N Trapaidze; I Gomes; M Bansinath; L A Devi
Journal:  DNA Cell Biol       Date:  2000-04       Impact factor: 3.311

3.  Activation and internalization of the mu-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2.

Authors:  K McConalogue; E F Grady; J Minnis; B Balestra; M Tonini; N C Brecha; N W Bunnett; C Sternini
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

4.  The enigma of morphine tolerance: recent insights.

Authors:  S B Ray; S Wadhwa
Journal:  J Biosci       Date:  2001-12       Impact factor: 1.826

5.  Neurotrophin-regulated sorting of opioid receptors in the biosynthetic pathway of neurosecretory cells.

Authors:  Kyung-Ah Kim; Mark von Zastrow
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

Review 6.  Visualizing activation of opioid circuits by internalization of G protein-coupled receptors.

Authors:  Kevin Sinchak; Paul Micevych
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

7.  Chronic morphine treatment reduces recovery from opioid desensitization.

Authors:  Vu C Dang; John T Williams
Journal:  J Neurosci       Date:  2004-09-01       Impact factor: 6.167

Review 8.  G protein-coupled receptor kinase/beta-arrestin systems and drugs of abuse: psychostimulant and opiate studies in knockout mice.

Authors:  Laura M Bohn; Raul R Gainetdinov; Marc G Caron
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

9.  Chronic methadone treatment shows a better cost/benefit ratio than chronic morphine in mice.

Authors:  Johan Enquist; Madeline Ferwerda; Laura Milan-Lobo; Jennifer L Whistler
Journal:  J Pharmacol Exp Ther       Date:  2011-11-07       Impact factor: 4.030

Review 10.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.